The detection of dMMR status in a tumor can influence treatment decisions. For instance, patients with dMMR colorectal cancer may benefit from immunotherapy rather than traditional chemotherapy. Similarly, dMMR status can guide the use of targeted therapies and participation in clinical trials designed to exploit the vulnerabilities of MMR-deficient tumors.
